Nodal metastasis in non-small cell lung cancer: Accuracy of 3.0-T MR imaging

Radiology

Volumn 246, Issue 2, 2008, Pages 596-604

  Ha, Young Kim ^a   Yi, Chin A ^a   Kyung, Soo Lee ^a   Myung, Jin Chung ^a   Yoon, Kyung Kim ^a   Bong, Keun Choi ^b   Kim, Hojoong ^a   Kwon, O Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CARCINOID; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; INFORMED CONSENT; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; RISK; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SPIN LABELING; SQUAMOUS CELL CARCINOMA; THREE DIMENSIONAL ECHOCARDIOGRAPHY; THREE DIMENSIONAL IMAGING; IMAGE ENHANCEMENT; LUNG TUMOR; MEDIASTINUM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; IMAGE ENHANCEMENT; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MEDIASTINUM; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 39549100998     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2461061907     Document Type: Article

References (39)

1. Ohno Y, Sugimura K, Hatabu H. MR imaging of lung cancer. Eur J Radiol 2002;44:172-181.
2. Libshitz HI, McKenna RJ Jr, Haynie TP, McMurtrey MJ, Mountain CT. Mediastinal evaluation in lung cancer. Radiology 1984;151:295-299.
3. Musset D, Grenier P, Carette MF, et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 1986;160:607-611.
4. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319-323.
5. Seely JM, Mayo JR, Miller RR, Muller NL. T1 lung cancer: prevalence of mediastinal nodal metastases and diagnostic accuracy of CT. Radiology 1993;186:129-132.
6. Scott WJ, Gobar LS, Terry JD, Dewan NA, Sunderland JJ. Mediastinal lymph node staging of non-small-cell lung cancer: a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996;111:642-648.
7. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-713.
8. Gupta NC, Tamim WJ, Graeber GG, Bishop HA, Hobbs GR. Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging. Chest 2001;120:521-527.
9. Shim SS, Lee KS, Kim BT, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging. Radiology 2005;236:1011-1019.
10. Dwamena BA, Sonnad SS, Angobaldo JO, Wahl RL. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s - meta-analytic comparison of PET and CT. Radiology 1999;213:530-536.
11. Erasmus JJ, Truong MT, Munden RF. CT, MR, and PET imaging in staging of non-small-cell lung cancer. Semin Roentgenol 2005;40:126-142.
12. Webb WR. MR imaging in the evaluation and staging of lung cancer. Semin Ultrasound CT MR 1988;9:53-66.
13. Boiselle PM, Patz EF Jr, Vining DJ, Weissleder R, Shepard JA, McLoud TC. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. RadioGraphics 1998;18:1061-1069.
14. Kauczor HU, Kreitner KF. Contrast-enhanced MRI of the lung. Eur J Radiol 2000;34:196-207.
15. Templeton PA, Caskey CI, Zerhouni EA. Current uses of CT and MR imaging in the staging of lung cancer. Radiol Clin North Am 1990;28:631-646.
16. Glazer GM, Orringer MB, Chenevert TL, et al. Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. Radiology 1988;168:429-431.
17. Ohno Y, Hatabu H, Takenaka D, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative and qualitative assessment with STIR turbo spin-echo MR imaging. Radiology 2004;231:872-879.
18. Takahashi M, Uematsu H, Hatabu H. MR imaging at high magnetic fields. Eur J Radiol 2003;46:45-52.
19. Brown MA, Semelka RC. MR imaging abbreviations, definitions, and descriptions: a review. Radiology 1999;213:647-662.
20. Walker R, Kessar P, Blanchard R, et al. Turbo STIR magnetic resonance imaging as a whole-body screening tool for metastases in patients with breast carcinoma: preliminary clinical experience. J Magn Reson Imaging 2000;11:343-350.
21. Viano AM, Gronemeyer SA, Haliloglu M, Hoffer FA. Improved MR imaging for patients with metallic implants. Magn Reson Imaging 2000;18:287-295.
22. Eustace S, Tello R, DeCarvalho V, Carey J, Melhem E, Yucel EK. Whole body turbo STIR MRI in unknown primary tumor detection. J Magn Reson Imaging 1998;8:751-753.
23. Takenaka D, Ohno Y, Hatabu H, et al. Differentiation of metastatic versus non-metastatic mediastinal lymph nodes in patients with non-small cell lung cancer using respiratory-triggered short inversion time inversion recovery (STIR) turbo spin-echo MR imaging. Eur J Radiol 2002;44:216-224.
24. Hatabu H, Gaa J, Tadamura E, et al. MR imaging of pulmonary parenchyma with a half-Fourier single-shot turbo spin-echo (HASTE) sequence. Eur J Radiol 1999;29:152-159.
25. Yamashita Y, Yokoyama T, Tomiguchi S, Takahashi M, Ando M. MR imaging of focal lung lesions: elimination of flow and motion artifact by breath-hold ECG-gated and black-blood techniques on T2-weighted turbo SE and STIR sequences. J Magn Reson Imaging 1999;9:691-698.
26. Esen G. Ultrasound of superficial lymph nodes. Eur J Radiol 2006;58:345-359.
27. Krestan C, Herneth AM, Formanek M, Czerny C. Modern imaging lymph node staging of the head and neck region. Eur J Radiol 2006;58:360-366.
28. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718-1723.
29. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
30. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York, NY: Wiley, 1982; 447-456.
31. Sundaram M, McGuire MH, Schajowicz F. Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images. AJR Am J Roentgenol 1987;148:1247-1250.
32. Chakraborti KL, Jena A. MR evaluation of the mediastinal lymph nodes. Indian J Chest Dis Allied Sci 1997;39:19-25.
33. Wiener JI, Chako AC, Merten CW, Gross S, Coffey EL, Stein HL. Breast and axillary tissue MR imaging: correlation of signal intensities and relaxation times with pathologic findings. Radiology 1986;160:299-305.
34. Boiselle PM. MR imaging of thoracic lymph nodes: a comparison of computed tomography and positron emission tomography. Magn Reson Imaging Clin N Am 2000;8:33-41.
35. Quint LE, Francis IR, Wahl RL, Gross BH, Glazer GM. Preoperative staging of non-small-cell carcinoma of the lung: imaging methods. AJR Am J Roentgenol 1995;164:1349-1359.
36. Willinek WA, Born M, Simon B, et al. Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging - initial experience. Radiology 2003;229:913-920.
37. Campeau NG, Huston J 3rd, Bernstein MA, Lin C, Gibbs GF. Magnetic resonance angiography at 3.0 Tesla: initial clinical experience. Top Magn Reson Imaging 2001;12:183-204.
38. Robitaille PM, Abduljalil AM, Kangarlu A. Ultra high resolution imaging of the human head at 8 tesla: 2K x 2K for Y2K. J Comput Assist Tomogr 2000;24:2-8.
39. Thulborn KR. Clinical rationale for very-high-field (3.0 Tesla) functional magnetic resonance imaging. Top Magn Reson Imaging 1999;10:37-50.